HBI-002

The up-regulation of the heme oxygenase enzyme and increases in its metabolites have been shown to reduce inflammation and apoptosis in animal models of concussion and other cerebral injury, sickle cell disease and kidney transplant, as well as a number of other conditions.  HBI-002 is an orally available formulation of the best studied molecule to up-regulate heme oxygenase. This gasotransmitter, carbon monoxide, is also a metabolite of the heme oxygenase pathway.   This formulation is being studied in cerebral injury, sickle cell disease and kidney transplant.

 

Targeting Debilitating and Life Threatening Inflammation